Table 3.
IT | ET65 | ET80 | WT1 | WT2 | WT1 | WT2 | |
---|---|---|---|---|---|---|---|
Ppeak(W) | tmax (s) | tmax (s) | Pmax (W) | Pmax (W) | Pmean (W) | Pmean (W) | |
BSL | 308 ± 24 | 2130 ± 750 | 714 ± 252 | 1135 ± 66 | 779 ± 50 | 730 ± 32 | 527 ± 38 |
INT | 320 ± 23* | ND | 1044 ± 372 | 1079 ± 32 | 908 ± 66 | 763 ± 29 | 570 ± 38* |
END | 327 ± 22* | 3420 ± 1212* | 1224 ± 432* | 1147 ± 65 | 885 ± 47 | 792 ± 42 | 580 ± 35* |
VO2 peak (mmol*l−1) | VO2 peak (mmol*l−1) | VO2 peak (mmol*l−1) | VO2 peak (mmol*l−1) | VO2 peak (mmol*l−1) | VO2 mean (mmol*l−1) | VO2 mean (mmol*l−1) | |
BSL | 3.71 ± 0.30 | 2.74 ± 0.25 | 3.16 ± 0.27 | 2.54 ± 0.27 | 1.78 ± 0.08 | 1.85 ± 0.19 | 1.69 ± 0.11 |
INT | 3.84 ± 0.20 | ND | 3.56 ± 0.18 | 2.86 ± 0.36 | 2.09 ± 0.18 | 2.12 ± 0.27 | 1.90 ± 0.12 |
END | 3.81 ± 0.20 | 2.81 ± 0.37 | 3.62 ± 0.17 | 2.33 ± 0.47 | 2.25 ± 0.23 | 1.73 ± 0.32 | 2.04 ± 0.18 |
VCO2 peak (mmol*l−1) | VCO2 peak (mmol*l−1) | VCO2 peak (mmol*l−1) | VCO2 peak (mmol*l−1) | VCO2 peak (mmol*l−1) | VCO2 mean (mmol*l−1) | VCO2 mean (mmol*l−1) | |
BSL | 4.05 ± 0.22 | 2.74 ± 0.13 | 3.51 ± 0.15 | 2.93 ± 0.42 | 3.46 ± 0.24 | 2.03 ± 0.30 | 3.30 ± 0.16 |
INT | 4.24 ± 0.21 | ND | 3.35 ± 0.15 | 3.16 ± 0.42 | 3.51 ± 0.25 | 2.22 ± 0.31 | 3.25 ± 0.23 |
END | 4.25 ± 0.15 | 2.63 ± 0.12 | 3.41 ± 0.16 | 2.68 ± 0.57 | 3.78 ± 0.24 | 1.88 ± 0.38 | 3.45 ± 0.22 |
Lactaterest (mmol*l−1) | Lactaterest (mmol*l−1) | Lactaterest (mmol*l−1) | Lactaterest (mmol*l−1) | Lactaterest (mmol*l−1) | |||
BSL | 0.85 ± 0.05 | 0.79 ± 0.08 | 1.02 ± 0.13 | 0.86 ± 0.06 | NA | ||
INT | 0.86 ± 0.11 | ND | 0.94 ± 0.12 | 0.72 ± 0.12 | NA | ||
END | 0.78 ± 0.10 | 0.84 ± 0.09 | 0.80 ± 0.10 | 0.83 ± 0.10 | NA | ||
Lactateend (mmol*l−1) | Lactateend (mmol*l−1) | Lactateend (mmol*l−1) | Lactateend (mmol*l−1) | Lactateend (mmol*l−1) | |||
BSL | 12.76 ± 1.11 | 8.46 ± 1.28 | 12.05 ± 1.20 | 5.57 ± 0.72 | 11.64 ± 0.62 | ||
INT | 12.00 ± 1.17 | ND | 12.90 ± 1.11 | 5.33 ± 0.83 | 12.70 ± 0.80 | ||
END | 12.87 ± 1.10 | 7.02 ± 1.35 | 12.09 ± 1.00 | 7.00 ± 0.64 | 13.31 ± 0.78 | ||
Glucoserest (mmol*l−1) | Glucoserest (mmol*l−1) | Glucoserest (mmol*l−1) | Glucoserest (mmol*l−1) | Glucoserest (mmol*l−1) | |||
BSL | 5.29 ± 0.15 | 5.31 ± 0.20 | 5.19 ± 0.21 | 5.11 ± 0.18 | NA | ||
INT | 5.14 ± 0.18 | ND | 5.41 ± 0.31 | 4.68 ± 0.17 | NA | ||
END | 5.41 ± 0.21 | 5.15 ± 0.13 | 5.61 ± 0.20 | 4.97 ± 0.16 | NA | ||
Glucoseend (mmol*l−1) | Glucoseend (mmol*l−1) | Glucoseend (mmol*l−1) | Glucoseend (mmol*l−1) | Glucoseend (mmol*l−1) | |||
BSL | 4.73 ± 0.28 | 4.75 ± 0.29 | 4.44 ± 0.33 | 4.28 ± 0.17 | 4.30 ± 0.16 | ||
INT | 4.68 ± 0.12 | ND | 5.45 ± 0.44 | 4.70 ± 0.07 | 4.87 ± 0.07 | ||
END | 4.38 ± 0.22 | 5.04 ± 0.33 | 4.93 ± 0.32 | 4.55 ± 0.10 | 4.72 ± 0.16 | ||
Trirest (mmol*l−1) | Trirest (mmol*l−1) | Trirest (mmol*l−1) | Trirest (mmol*l−1) | Trirest (mmol*l−1) | |||
BSL | ND | 1.09 ± 0.19 | 1.09 ± 0.07 | 1.29 ± 0.25 | NA | ||
INT | ND | ND | 1.63 ± 0.28 | 1.30 ± 0.21 | NA | ||
END | ND | 1.32 ± 0.18 | 1.25 ± 0.23 | 1.29 ± 0.23 | NA | ||
Triend (mmol*l−1) | Triend (mmol*l−1) | Triend (mmol*l−1) | Triend (mmol*l−1) | Triend (mmol*l−1) | |||
BSL | ND | 1.21 ± 0.11 | 1.35 ± 0.08 | 1.43 ± 0.31 | 1.60 ± 0.39 | ||
INT | ND | ND | 1.75 ± 0.31 | 1.39 ± 0.27 | 1.49 ± 0.29 | ||
END | ND | 1.23 ± 0.19 | 1.51 ± 0.23 | 1.61 ± 0.29 | 1.61 ± 0.27 |
Performance and respiratory parameters during and metabolic parameters at rest (rest) and at the end (end) of incremental test (IT), endurance tests at 65% Pmax (ET65) and at 80% Pmax (ET80), and Wingate tests 1 and 2 (WT1 and 2) at BSL, INT and END testing sessions. Data are presented as means ± SE. Pmax: maximum power; P mean, mean power; Ppeak, peak power; tmax, time-to-exhaustion; Tri, triglycerides; NA, not applicable; ND, not determined.
Significantly different from BSL testing, p < 0.05.